Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Petersen

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
The International Journal of Neuropsychopharmacology|September 14, 2004
Obesity among outpatients with major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
Journal of Clinical Psychopharmacology|July 3, 2004
Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorderGeorge I Papakostas, Dan V Iosifescu, Timothy Petersen, et al.
Psychiatry Research|June 12, 2003
Axis III disorders in treatment-resistant major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
Journal of Clinical Psychopharmacology|November 13, 2004
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxineJonathan E Alpert, George Papakostas, David Mischoulon, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapyGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Electrophysiological analyses of human dorsal root ganglia and human induced pluripotent stem cell-derived sensory neurons from male and female donorsNesia A Zurek, Reza Ehsanian, Aleyah E Goins, et al.
Journal of Affective Disorders|April 13, 2025
Preliminary efficacy of prolonged exposure therapy to reduce suicide risk in co-occurring bipolar disorder & trauma symptomsDouglas Katz, Timothy Petersen, Dustin J Rabideau, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Empirical testing of two models for staging antidepressant treatment resistanceTimothy Petersen, George I Papakostas, Michael A Posternak, et al.
Psychopharmacology Bulletin|March 26, 2008
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trialTimothy Petersen, Roy H Perlis, Chris Ticknor, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
The International Journal of Neuropsychopharmacology|September 14, 2004
Obesity among outpatients with major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
Journal of Clinical Psychopharmacology|July 3, 2004
Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorderGeorge I Papakostas, Dan V Iosifescu, Timothy Petersen, et al.
Psychiatry Research|June 12, 2003
Axis III disorders in treatment-resistant major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
Journal of Clinical Psychopharmacology|November 13, 2004
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxineJonathan E Alpert, George Papakostas, David Mischoulon, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapyGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Electrophysiological analyses of human dorsal root ganglia and human induced pluripotent stem cell-derived sensory neurons from male and female donorsNesia A Zurek, Reza Ehsanian, Aleyah E Goins, et al.
Journal of Affective Disorders|April 13, 2025
Preliminary efficacy of prolonged exposure therapy to reduce suicide risk in co-occurring bipolar disorder & trauma symptomsDouglas Katz, Timothy Petersen, Dustin J Rabideau, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Empirical testing of two models for staging antidepressant treatment resistanceTimothy Petersen, George I Papakostas, Michael A Posternak, et al.
Psychopharmacology Bulletin|March 26, 2008
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trialTimothy Petersen, Roy H Perlis, Chris Ticknor, et al.
Pageof 6